Regulatory PathRegulatory requirements compared

Active substances

Dextromethorphan + Guaifenesin

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CONTRA 15/200 mg softgel capsule15,200 mg,mgCapsule, soft · Oral use30 BlisterSAR 29.75Generic · PrescriptionJamjoom Pharmaceuticals Factory CompanyValid
GUAPHAN DM100,10 mg,mgSyrup · Oral use1 BottleSAR 12.20Generic · PrescriptionRIYADH PHARMAValid
CHERACHOL-D SYRUP2, 20 mg/mlOral solution · Oral use1 BottleSAR 9.30NCE · OTCPHARMACIA UPJOHNWithdrawn by MAH · Not Marketed
KAFOSED G SYRUPSyrup · Oral use1 BottleSAR 5.15Generic · PrescriptionSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
ROBITUSSIN-DM SYRUP3, 20 mgSyrup · Oral use1 BottleSAR 7.40Generic · PrescriptionFEREVA RICHMONDWithdrawn by MAH · Not Marketed
VICKS 44 E PEDIATRIC ALCOHOL FREE SYRUP100,10 mg,mgSyrup · Oral use1 BottleSAR 5.10Generic · PrescriptionPROCTER & GAMBLEWithdrawn by regulatory authority · Not Marketed
Indications — CHI Daman Drug Formulary

BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
MUCINEX DM60MG;1.2GM; 30MG;600MGtablet, extended release · oralRECKITT BENCKISEROver-the-counter29 Apr 2004
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE30MG;600MG; 60MG;1.2GMtablet, extended release · oralACTAVIS LABS FLOver-the-counter31 Aug 2015
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE30MG;600MG; 60MG;1.2GMtablet, extended release · oralAUROBINDO PHARMAOver-the-counter17 Mar 2017
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE60MG;1.2GM; 30MG;600MGtablet, extended release · oralPERRIGO R AND DOver-the-counter5 Mar 2018
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE30MG;600MG; 60MG;1.2GMtablet, extended release · oralAMNEAL PHARMSOver-the-counter1 Nov 2018
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE30MG;600MG; 60MG;1.2GMtablet, extended release · oralSUN PHARMOver-the-counter1 Jul 2021
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE30MG;600MG; 60MG;1.2GMtablet, extended release · oralDR REDDYSOver-the-counter1 Aug 2023

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF0194476215 MG / 5 ML; 100 MG / 5 MLSYRUP · ORALKENVUE CANADA INC.
COUGH & CHEST CONGESTION0253919520 MG / 20 ML; 400 MG / 20 MLSYRUP · ORALLSL MEDPLUS INC
COUGH & CHEST CONGESTION EXTRA STRENGTH0254189015 MG / 5 ML; 200 MG / 5 MLSYRUP · ORALCRLS
COUGH & CHEST CONGESTION REGULAR STRENGTH02541882100 MG / 5 ML; 15 MG / 5 MLSYRUP · ORALCRLS
JACK & JILL HONEY COUGH & COLD0252295050 MG / 5 ML; 5 MG / 5 MLSYRUP · ORALHALEON CANADA ULC
MUCINEX CONGESTION & COUGH0243325720 MG / 20 ML; 400 MG / 20 MLSOLUTION · ORALRECKITT BENCKISER (CANADA) INC
MUCUS & PHLEGM RELIEF WITH COUGH CONTROL EXTRA STRENGTH02540908200 MG / 5 ML; 15 MG / 5 MLSYRUP · ORALCRLS
ROBITUSSIN COUGH CONTROL01931024100 MG / 5 ML; 15 MG / 5 MLSYRUP · ORALHALEON CANADA ULC
ROBITUSSIN EXTRA STRENGTH COUGH CONTROL0214277515 MG / 5 ML; 200 MG / 5 MLSYRUP · ORALHALEON CANADA ULC
ROBITUSSIN EXTRA STRENGTH HONEY COUGH & CONGESTION02485524400 MG / 20 ML; 20 MG / 20 MLSYRUP · ORALHALEON CANADA ULC
ROBITUSSIN SUGAR FREE COUGH CONTROL0224856810 MG / 5 ML; 100 MG / 5 MLSYRUP · ORALGLAXOSMITHKLINE CONSUMER HEALTHCARE ULC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACGUAIFENESIN-DM 100-10 MG/5 ML$0.02395per ML23 Sep 2026
US NADACGUAIFENESIN-DM ER 1,200-60 MG$0.54461per EA7 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.